Araştırma Makalesi
BibTex RIS Kaynak Göster

Validity and reliability of the Turkish version of the Brief Medication Questionnaire

Yıl 2023, Cilt: 62 Sayı: 1, 95 - 102, 15.03.2023

Öz

Aim: The aim of this study was to adapt the Brief Medication Questionnaire (BMQ), a scale that screens the barriers to adherence to treatment, into Turkish and to test validity and reliability of it..
Materials and Methods: The study was included 106 patients with hypertension and using antihypertensive drugs aged 18 years and over. Translation and adaptation processes were carried
out following the steps recommended by World Health Organization. Hill-Bone Compliance to High Blood Pressure Therapy Scale was administered simultaneously to the participants. Cronbach's alpha was used to analyze the internal consistency of the scale.
Results: Of the participants, 65 were female and 41 were male, with a mean systolic blood pressure of 140.6±20.1 mmHg, a mean diastolic blood pressure of 80.8±11.2 mmHg, and a mean heart rate of
80.4±11.5 beats/min. According to Hill-Bone, 79 people (74.5%) had, and according to BMQ, 46 people (43.4%) had adherence problems. The most common reasons for non-adherence were regime (28.3%) and access (19.8%). The Cronbach’s alpha score of BMQ was 0.616. There was a statistically positive significant correlation between BMQ and Hill-Bone (r=0.81, p<0.001).
Conclusion: Turkish version of BMQ is valid and reliable instrument and can be used in the evaluation of medication adherence.

Kaynakça

  • Global Health Estimates 2016: Deaths by Cause, Age, Sex, by Country and by Region, 2000–2016. Geneva: World Health Organization; 2018.
  • Noncommunicable diseases country profiles 2018. Geneva: World Health Organization; 2018.
  • Sabate E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
  • World Health Organisation. Promoting rational use of Medicines. https://www.who.int/activities/promotingrational-use-of-medicines/ Erişim tarihi: 20.01.2022.
  • Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34:2159–219. https://doi.org/10.1093/eurheartj/eht151.
  • Prevalence and hypertension cascade data are from the Turkey 2017 STEPwise approach to noncommunicable disease risk factor surveillance (STEPS) survey. https://extranet.who.int/ncdsmicrodata/
  • Aydoğdu S, Güler K, Bayram F, Altun B, Derici Ü ve ark,. 2019 Turkish Hypertension Consensus Report. Turk Kardiyol Dern Ars. 2019; 47(6): 535-46. doi: 10.5543/tkda.2019.62565.
  • Tavşancıl E. 2018. Tutumların Ölçülmesi ve SPSS ile veri analizi. 6. Baskı Nobel Tıp Kitabevi.
  • BP monitors. British and Irish Hypertension Society. https://bihsoc.org/bp-monitors/ Erişim tarihi: 20.01.2022.
  • World Health Organisation, Obesity and overweight. https://www.who.int/news-room/factsheets/detail/obesity-and-overweight. Erişim tarihi: 20.01.2022.
  • Process of translation and adaptation of instruments, http://www.who.int/substance_abuse/research_tools/translation/en. Erişim tarihi: 20.01.2022.
  • Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999 Jun; 37 (2): 113-24. doi: 10.1016/s0738-3991 (98) 00107-4.
  • Kim MT, Hill MN, Bone LR, Levine DM . Development and testing of the Hill–Bone compliance to high blood pressure therapy scale . Prog Cardiovasc Nurs . 2000;15: 90–6.
  • Karademir, M., Köseoğlu, IH., Vatansever , K., Akker, MVD' Validity and reliability of the Turkish version of the Hill-Bone compliance to high blood pressure therapy scale for use in primary health care settings' The European Journal of General Practice, 2009 1115: 4, 207 — 11.
  • Ben AJ, Neumann CR, Mengue SS. The Brief Medication Questionnaire and Morisky-Green test to evaluate medication adherence. Rev Saude Publica. 2012 Apr; 46 (2): 279-89. English, Portuguese. doi: 10.1590/s0034-89102012005000013.
  • Bhusal A, Jadhav PR, Deshmukh YA. Assessment of medication adherence among hypertensive patients: a cross-sectional study.Int J Basic Clin Pharmacol 2016; 5: 1606-12.
  • Roy NT, Sajith M, Bansode MP. Assessment of Factors Associated with Low Adherence to Pharmacotherapy in Elderly Patients. J Young Pharm. 2017; 9 (2): 272-6.
  • Thomas D, Meera NK, Binny K, Sekhar SM, Kishore G, Sasidharan S. Medication adherence and associated barriers in hypertension management in India. CVD Prevention and Control, vol. 6, pp. 9 - 13, 2011.
  • Demirbas N, Kutlu R. Treatment Adherence And Self-Efficacy Levels Of Adults Using Multiple Drugs. Ankara Med J. 2020; 20 (2): 269-80.
  • Demirbağ BC, Timur M. Bir Grup Yaşlının İlaç Kullanımı İle İlgili Bilgi, Tutum ve Davranışları. Ankara Sağlık Hizmetleri Dergisi 2012; 11 (1): 1-8.
  • Karakurt P, Kaşikçi M. Factors affecting medication adherence in patients with hypertension. J Vasc Nurs. 2012 Dec; 30 (4): 118-26. doi: 10.1016/j.jvn.2012.04.002.
  • Ranasinghe P, Jayawardena R, Katulanda P, Constantine GR, Ramanayake V, Galappatthy P. Translation and Validation of the Sinhalese Version of the Brief Medication Questionnaire in Patients with Diabetes Mellitus. J Diabetes Res. 2018 May 23;2018:7519462. doi: 10.1155/2018/7519462.
  • Perwitasari DA, Urbayatun S. Treatment Adherence and Quality of Life in Diabetes Mellitus Patients in Indonesia. SAGE Open. April 2016. doi:10.1177/2158244016643748.

Kısa İlaç Anketi'nin Türkçe geçerliliği ve güvenilirliği

Yıl 2023, Cilt: 62 Sayı: 1, 95 - 102, 15.03.2023

Öz

Amaç: Bu çalışmanın amacı, tedaviye uyumun önündeki engelleri tarayan Kısa İlaç Anketi'nin (KİA) Türkçe'ye uyarlanması, geçerlik ve güvenirliğinin test edilmesidir.
Gereç ve Yöntem: Çalışma, hipertansiyon tanısı konmuş ve antihipertansif ilaç kullanan 18 yaş veüzeri 106 kişi ile yürütüldü. Çeviri ve uyarlama işlemleri Dünya Sağlık Örgütü tarafından önerilen
adımlar izlenerek gerçekleştirildi. Katılımcılara Hill-Bone Hipertansiyon Tedavisine Uyum Ölçeği (HillBone HTUÖ) eş zamanlı uygulandı. Ölçeğin iç tutarlılığını analiz etmek için Cronbach's alpha kullanıldı.
Bulgular: Katılımcıların 65’i kadın, 41’i erkek olup, ortalama sistolik kan basınçları 140,6±20,1 mmHg, ortalama diyastolik kan basınçları 80,8±11,2 mmHg ve ortalama kalp hızları 80,4±11,5 atım/dk olarak
saptandı. Hill-Bone HTUÖ’ye göre 79 kişide (% 74,5) uyumsuzluk, KİA’ya göre ise 46 kişide (% 43,4) uyum sorunları olduğu görüldü. En fazla uyumsuzluk sebepleri rejim (% 28,3 ) ve erişim (% 19,8) oldu.
KİA ölçeğinin cronbach alpha katsayı değeri 0,616 olarak tespit edildi. KİA ile Hill-Bone HTUÖ sonuçları arasında istatistiksel olarak pozitif yönlü güçlü korelasyon olduğu belirlendi (r=0.81,
p<0.001).
Sonuç: KİA’nın Türkçe versiyonu, geçerli ve güvenilir olup ilaç uyumunun değerlendirilmesinde kullanılabilir.

Kaynakça

  • Global Health Estimates 2016: Deaths by Cause, Age, Sex, by Country and by Region, 2000–2016. Geneva: World Health Organization; 2018.
  • Noncommunicable diseases country profiles 2018. Geneva: World Health Organization; 2018.
  • Sabate E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
  • World Health Organisation. Promoting rational use of Medicines. https://www.who.int/activities/promotingrational-use-of-medicines/ Erişim tarihi: 20.01.2022.
  • Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34:2159–219. https://doi.org/10.1093/eurheartj/eht151.
  • Prevalence and hypertension cascade data are from the Turkey 2017 STEPwise approach to noncommunicable disease risk factor surveillance (STEPS) survey. https://extranet.who.int/ncdsmicrodata/
  • Aydoğdu S, Güler K, Bayram F, Altun B, Derici Ü ve ark,. 2019 Turkish Hypertension Consensus Report. Turk Kardiyol Dern Ars. 2019; 47(6): 535-46. doi: 10.5543/tkda.2019.62565.
  • Tavşancıl E. 2018. Tutumların Ölçülmesi ve SPSS ile veri analizi. 6. Baskı Nobel Tıp Kitabevi.
  • BP monitors. British and Irish Hypertension Society. https://bihsoc.org/bp-monitors/ Erişim tarihi: 20.01.2022.
  • World Health Organisation, Obesity and overweight. https://www.who.int/news-room/factsheets/detail/obesity-and-overweight. Erişim tarihi: 20.01.2022.
  • Process of translation and adaptation of instruments, http://www.who.int/substance_abuse/research_tools/translation/en. Erişim tarihi: 20.01.2022.
  • Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999 Jun; 37 (2): 113-24. doi: 10.1016/s0738-3991 (98) 00107-4.
  • Kim MT, Hill MN, Bone LR, Levine DM . Development and testing of the Hill–Bone compliance to high blood pressure therapy scale . Prog Cardiovasc Nurs . 2000;15: 90–6.
  • Karademir, M., Köseoğlu, IH., Vatansever , K., Akker, MVD' Validity and reliability of the Turkish version of the Hill-Bone compliance to high blood pressure therapy scale for use in primary health care settings' The European Journal of General Practice, 2009 1115: 4, 207 — 11.
  • Ben AJ, Neumann CR, Mengue SS. The Brief Medication Questionnaire and Morisky-Green test to evaluate medication adherence. Rev Saude Publica. 2012 Apr; 46 (2): 279-89. English, Portuguese. doi: 10.1590/s0034-89102012005000013.
  • Bhusal A, Jadhav PR, Deshmukh YA. Assessment of medication adherence among hypertensive patients: a cross-sectional study.Int J Basic Clin Pharmacol 2016; 5: 1606-12.
  • Roy NT, Sajith M, Bansode MP. Assessment of Factors Associated with Low Adherence to Pharmacotherapy in Elderly Patients. J Young Pharm. 2017; 9 (2): 272-6.
  • Thomas D, Meera NK, Binny K, Sekhar SM, Kishore G, Sasidharan S. Medication adherence and associated barriers in hypertension management in India. CVD Prevention and Control, vol. 6, pp. 9 - 13, 2011.
  • Demirbas N, Kutlu R. Treatment Adherence And Self-Efficacy Levels Of Adults Using Multiple Drugs. Ankara Med J. 2020; 20 (2): 269-80.
  • Demirbağ BC, Timur M. Bir Grup Yaşlının İlaç Kullanımı İle İlgili Bilgi, Tutum ve Davranışları. Ankara Sağlık Hizmetleri Dergisi 2012; 11 (1): 1-8.
  • Karakurt P, Kaşikçi M. Factors affecting medication adherence in patients with hypertension. J Vasc Nurs. 2012 Dec; 30 (4): 118-26. doi: 10.1016/j.jvn.2012.04.002.
  • Ranasinghe P, Jayawardena R, Katulanda P, Constantine GR, Ramanayake V, Galappatthy P. Translation and Validation of the Sinhalese Version of the Brief Medication Questionnaire in Patients with Diabetes Mellitus. J Diabetes Res. 2018 May 23;2018:7519462. doi: 10.1155/2018/7519462.
  • Perwitasari DA, Urbayatun S. Treatment Adherence and Quality of Life in Diabetes Mellitus Patients in Indonesia. SAGE Open. April 2016. doi:10.1177/2158244016643748.
Toplam 23 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Konular Sağlık Kurumları Yönetimi
Bölüm Araştırma Makaleleri
Yazarlar

Yasin Altun

Yayımlanma Tarihi 15 Mart 2023
Gönderilme Tarihi 22 Ocak 2022
Yayımlandığı Sayı Yıl 2023Cilt: 62 Sayı: 1

Kaynak Göster

Vancouver Altun Y. Kısa İlaç Anketi’nin Türkçe geçerliliği ve güvenilirliği. ETD. 2023;62(1):95-102.

1724617243172472652917240      26515    

 26507    26508 26517265142651826513

2652026519